Other Event

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event

Ignite Creation Date: 2025-12-24 @ 2:03 PM
Ignite Modification Date: 2025-12-25 @ 12:47 PM
NCT ID: NCT02799095
Term: Chills
Organ System: General disorders
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA version 25.0
Notes: None
Study: NCT02799095
Study Brief: A Study of the Effects of ALKS 4230 (Nemvaleukin Alfa) on Subjects With Solid Tumors
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG003 29 8 8 View
EG004 52 11 12 View
EG005 32 3 3 View
EG006 2 2 7 View
EG007 226 21 47 View
EG008 47 14 27 View
EG009 3 1 3 View
EG010 171 32 42 View
EG011 62 16 26 View
EG012 95 18 26 View
EG013 129 9 43 View
EG014 7 3 3 View
EG015 65 13 21 View
EG016 42 2 2 View
EG002 16 5 7 View
EG000 0 0 5 View
EG001 8 2 4 View